GLAUKOS Corp (GKOS) Latest Filing Signal

Latest Filing: 10-K  |  Filed Feb 23, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for GLAUKOS Corp?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, GLAUKOS Corp's filing signal turned negative.
earningsVibe SuperAnalyst™ Verdict: TURNED NEGATIVE

Signal Performance — Stock Price Since Filing

30-Day Change
-8.98%
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Negative
GEMINI
Turned Positive
CLAUDE
Turned Negative
CHATGPT
Turned Negative

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does GLAUKOS Corp actually do?
Answer:
Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company specializing in novel, dropless therapies for glaucoma, corneal disorders, and retinal diseases. The company pioneered Micro-Invasive Glaucoma Surgery (MIGS) with its iStent family of products, launched in 2012, and in 2024, began commercializing iDose TR, a sustained-release intracameral implant for glaucoma. Glaukos also offers bio-activated pharmaceutical therapies for corneal disorders, such as its iLink platform for keratoconus. The company's strategy focuses on advancing the standard of care through a robust pipeline of innovative, dropless platform technologies aimed at improving patient outcomes for chronic eye diseases.
Question:
What are GLAUKOS Corp's revenue drivers?
Answer:
Net sales are primarily generated from the iStent family of products, iDose TR, and Photrexa therapies, which together accounted for approximately 83% of net sales in 2025. The iLink therapies and associated products contributed the remaining 17% of net sales.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required